Dr. Stackhouse is the Associate Director for the Technology Transfer Center at the National Cancer Institute’s (NCI) campus at Frederick, Maryland. This campus includes the Frederick National Laboratory for Cancer Research (FNL), the only federally funded research and development center associated with the Department of Health and Human Services. In this position, Dr. Stackhouse oversees NCI-Frederick partnering activities through NCI Collaboration Agreements and CRADAs, and manages all of NCIs intellectual property portfolio. In addition to his role overseeing the technology activities of NCI-Frederick, Dr. Stackhouse manages the Marketing and Information Management Units for the NCI Technology Transfer Center. HE also has played the lead role in establishing the intellectual property parameters and guidelines for several key NCI initiatives that have been handled through the NCI campus at Frederick. Dr. Stackhouse works closely with local economic development groups such as TEDCO, and the Frederick and Montgomery county governments. He received his Ph.D. in Biochemistry from the University of California, Davis. Dr. Stackhouse worked for a major pharmaceutical company and was part of the research team of scientists who discovered the VHL tumor suppressor gene. He has twice received the National Institutes of Health Award of Merit for his outstanding management of the NCI-Frederick Technology Transfer Office. For his efforts on a team that developed the SBIR-Technology Transfer Program for the Institute, he received the 2012 Mid-Atlantic Region Technology Transfer Representative of the Year award.